Christopher G. Danes

Author

The University of Texas MD Anderson Cancer Center

Also Known As

C Danes, C.G. Danes, Christopher Danes, Christopher G. Danes, Christopher George Danes, Nagaraja, Archana S.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University at Albany, State University of New York Wadsworth Center Baylor College of Medicine Oregon Health & Science University

About

Christopher G. Danes is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	387
2	Cell Biology	4	4	387
3	Immunology	1	1	16
4	Pathology	1	1	174
5	Pharmacology	1	1	16

Christopher G. Danes

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms Donald C. Porter, Ning Zhang, Christopher G. Danes, Molecular and Cellular Biology	2001	197
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival Christopher L. Neal, Jun Yao, Wentao Yang, Cancer Research Tumor BiologyBreast Cancer RecurrenceBreast OncologyEndocrine-related CancerCancer Risk	2009	174
Therapeutic Targeting of ATP7B in Ovarian Carcinoma Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt, Clinical Cancer Research	2009	151
Functional significance of VEGFR‐2 on ovarian cancer cells Whitney A. Spannuth, Alpa M. Nick, Nicholas B. Jennings, International Journal of Cancer	2008	149
Processing of cyclin E differs between normal and tumor breast cells. Richard M. Harwell, Donald C. Porter, Christopher G. Danes, PubMed Breast OncologyG1 Cyclin EssentialMedicineCancer Cell BiologyCytopathology	2000	101
Erythropoietin Stimulates Tumor Growth via EphB4 Sunila Pradeep, Jie Huang, Edna Mora, Cancer Cell Tumor BiologyMedicineTumor SuppressorCancer BiologyCell Biology	2015	96
14-3-3ζ Down-regulates p53 in Mammary Epithelial Cells and Confers Luminal Filling Christopher G. Danes, Shannon L. Wyszomierski, Jing Lü, Cancer Research	2008	84
Dual targeting of EphA2 and FAK in ovarian carcinoma Mian M.K. Shahzad, Chunhua Lu, Jeong-Won Lee, Cancer Biology & Therapy	2009	63
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma William M. Merritt, Christopher G. Danes, Mian M.K. Shahzad, Cancer Biology & Therapy	2009	45
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis Cody Paiva, J. Claire Godbersen, Taylor Rowland, Oncotarget ApoptosisImmunologyCell DeathCancer BiologyCell Death Mechanisms	2017	16

Page 1